Asthma control and management in the community: Indices in 1997 compared with indices in 2002

Canadian Family Physician

Volumn 52, Issue 6, 2006, Pages 750-751

  Cowie, Robert L ^a,b,c   Underwood, Margot F ^a,b   Sin, Don D ^a,b   Sharpe, Heather M ^a,b   Bell, Neil R ^a,b   Man, S F Paul ^a,b  

^a Calgary COPD and Asthma Program   (Canada)

^b Alberta Strategy to Help Manage Asthma   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; ASTHMA; BEHAVIOR MODIFICATION; CANADA; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PATIENT EDUCATION; PHARMACIST; POPULATION MODEL; PRACTICE GUIDELINE; QUESTIONNAIRE;

EID: 33748789606     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ernst P, FitzGerald JM, Spier S. Canadian asthma consensus conference: summary of recommendations. Can Respir J 1996;3:89-100.
2. Boulet LP, Becker A, Berube D, Beveridge R, Ernst P. Canadian asthma consensus report, 1999. CMAJ 1999;161(11 Suppl):S1-62.
3. Chapman KR, Ernst P, Grenville A, Dewland P, Zimmerman S. Control of asthma in Canada: failure to achieve guideline targets. Can Respir J 2001;8(Suppl A):35-40A.
4. Bateman ED, Bousquet J, Braunstein GL. Is overall asthma control being achieved? A hypothesis-generating study. Eur Respir J 2001;17:589-95.
5. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma controL study. Am J Respir Crit Care Med 2004;170:836-44.
6. Cowie RL, Underwood MF, Mack S. The impact of asthma management guideline dissemination on the control of asthma in the community. Can Respir J 2001;8(Suppl A):41-5A.
7. Latvala J, von Hertzen L, Lindholm H, Haahtela T. Trends in prevalence of asthma and allergy in Finnish young men: nationwide study, 1966-2003. BMJ 2005;330:1186-7.
8. Cowie RL, Underwood MF, Revitt SG, Field SK. Predicting emergency room utilization in adults with asthma: a cohort study. J Asthma 2001;38:179-84.
9. Joyce DP, McIvor RA. Use of inhaled medications and urgent care services. Study of Canadian asthma patients. Can Fam Physician 1999;45:1707-13.
10. Cowie RL, Cicutto L, Boulet LP. Asthma education and management programs in Canada. Can Respir J 2001;8:416-20.
11. Sharpe HM, Sin DD, Andrews EM, Cowie RL, Man P. Alberta Strategy to Help Manage Asthma (ASTHMA): a provincial initiative to improve outcomes for individuals with asthma. Healthcare Q 2004;7:55-60.
12. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-24.
13. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-11.
14. Juniper EF, Svensson K, O'Byrne PM, Barnes PJ, Bauer CA, Lofdahl CG, et al. Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. Eur Respir J 1999;14:1038-43.
15. Jin R, Choi BC, Chan BT, McRae L, Li F, Cicutto L, et al. Physician asthma management practices in Canada. Can Respir J 2000;7:456-65.
16. Chapman KR, Walker L, Cluley S, Fabbri L. Improving patient compliance with asthma therapy. Respir Med 2000;94:2-9.
17. Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, et al. Self-management education and regular practitioner review for adults with asthma (Cochrane Review). Cochrane Database Syst Rev 2003;1:CD001117.
18. Corrigan S, David L, Cecillon D, Sin D, Sharpe H, Andrews E, et al. The costs of implementing the 1999 Canadian Consensus Guidelines recommendations for asthma education and spirometry. Can Respir J 2004;11:349-53.